Literature DB >> 20109422

Do-not-resuscitate orders and palliative care in patients who die in cardiology departments. What can be improved?

Manuel Martínez-Sellés1, Laura Gallego, Juan Ruiz, Francisco Fernández Avilés.   

Abstract

The use of do-not-resuscitate orders and palliative care was studied in 198 consecutive deaths of patients with heart disease that occurred in our department. In 113 (57%), it was decided not to resuscitate. The decision took into account the patient's medical history in 102 patients (90.3%) and departmental medical charts in 74 (65.5%). In total, 5 patients (4.4%) and 95 patients' families (84.1%) were informed. Little palliative treatment was used in patients with do-not-resuscitate orders: 56 (49.6%) received morphine and 5 (4.4%), spiritual support. However, prior to issuing the do-not-resuscitate order, these patients frequently received aggressive and expensive treatment such as orotracheal intubation in 49 (43.4%), coronary angiography in 27 (23.9%), inotropic drugs in 55 (48.7%) and intra-aortic balloon counterpulsation in 15 (13.3%). In conclusion, almost three-fifths of patients who died in a cardiology department had a do-not-resuscitate order. The decision to issue the order was frequently taken after administering aggressive treatment and little palliative care was provided afterward.

Entities:  

Mesh:

Year:  2010        PMID: 20109422     DOI: 10.1016/s1885-5857(10)70043-8

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  2 in total

Review 1.  Modification of Cardiovascular Drugs in Advanced Heart Failure: A Narrative Review.

Authors:  Manuel Martínez-Sellés; Tomasz Grodzicki
Journal:  Front Cardiovasc Med       Date:  2022-05-23

2.  End-of-life care in a cardiology department: have we improved?

Authors:  Juan Ruiz-Garcia; Pablo Diez-Villanueva; Ana Ayesta; Vanessa Bruña; Lourdes M Figueiras-Graillet; Laura Gallego-Parra; Francisco Fernández-Avilés; Manuel Martínez-Sellés
Journal:  J Geriatr Cardiol       Date:  2016-07       Impact factor: 3.327

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.